Objective: Aneurysms in Behcet's disease are rare, serious, and recurrent. To achieve durable treatment, patients should receive immunosuppressive therapy before intervention to induce remission. We present early and long-term results of emergency cases of active Behcet's disease, which did not permit waiting for suppressive treatment.
Patients And Methods: The study was undertaken on all cases admitted to the vascular unit, King Fahd Hospital of University for aneurysm treatment in patients with active Behcet's disease over about 10 years. All patients had exclusion of the aneurysm either by open surgery or endovascular intervention. Morbidities and mortality were recorded within the hospital admission and on the follow-up.
Results: During the study period, three cases were included. All interventions were successful and lifesaving. However, two cases, treated with surgical interposition grafts, were blocked in the intermediate term follow-up (2-12 months) and one case, treated with endovascular treatment, complicated with pseudoaneurysm at femoral puncture site after six months.
Conclusion: Although early results were good, intermediate ones were not satisfactory because of progressive graft thrombosis and formation of new aneurysms. Awareness of these rare cases help for early identification and proper immunosuppressive before emergency vascular intervention is warranted.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/1708538115611069 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prevalence of Antiphospholipid Antibody Syndrome Among Patients with Recurrent Pregnancy Loss: Impact of the Revised 2023 ACR/EULAR Antiphospholipid Syndrome Criteria.
J Clin Med
December 2024
Department of Internal Medicine and Clinical Immunology, University Hospital of Rennes, 35000 Rennes, France.
Current guidelines recommend systematic screening for rheumatic diseases (RDs), including antiphospholipid syndrome (APS), in patients with recurrent pregnancy loss (RPL). However, these recommendations are based on limited evidence, as data on the prevalence of RD in this specific population remain scarce. In particular, the impact of the recent update to the ACR/EULAR classification criteria for APS on the prevalence of RD among RPL patients has yet to be clarified.
View Article and Find Full Text PDFCholelithiasis in Infants: Risk Factors, Management, and the Role of Ursodeoxycholic Acid.
Children (Basel)
December 2024
Department of Pediatrics, Division of Pediatric Gastroenterology, University of Health Sciences Dr. Behçet Uz Children's Hospital, Izmir 35210, Turkey.
Background: Cholelithiasis is a rare disease in infants, and there is limited data on its risk factors and management.
Objectives: To evaluate the risk factors, management, and response to medical treatment of cholelithiasis in infants.
Methods: Infants diagnosed with cholelithiasis by ultrasound between 2018 and 2023 were retrospectively analyzed.
The association between abdominal ultrasound findings and clinical severity in MIS-C children with extracardiac symptoms.
Eur J Pediatr
January 2025
Department of Pediatric Intensive Care Unit, Dr. Behçet Uz Children Disease and Surgery Training and Research Hospital, University of Health Sciences, Izmir, Turkey.
Unlabelled: This study aimed to evaluate pathological findings on abdominal ultrasonography upon admission of children diagnosed with Multisystem Inflammatory Syndrome in Children (MIS-C) that were associated with a more severe disease course and the need for intensive care unit (ICU) admission. This retrospective and observational study was conducted between March 2020 and May 2022. Abdominal ultrasonography findings were evaluated in children diagnosed with MIS-C associated with SARS-CoV-2.
View Article and Find Full Text PDFUnlikely allies: Cholesterol, calcium, and cytokines drive neutrophil activation in Behcet's disease.
Cell Calcium
December 2024
Division of Rheumatology and Clinical Immunology, Departments of Medicine and Immunology, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address:
Article Synopsis
- The study examines the interplay between cholesterol, calcium, and cytokines in activating neutrophils, which are a type of white blood cell crucial for immune response.
- It highlights how these elements can contribute to the inflammation and immune dysfunction observed in Behcet's disease, a chronic condition characterized by recurrent ulcers and other symptoms.
- By understanding these relationships, the research aims to uncover potential targets for treatment, offering new insights into managing Behcet's disease more effectively.
Exploring the causal relationship between inflammatory cytokines, metabolites, and Behcet's syndrome: Mendelian randomization.
Cytokine
January 2025
Department of Periodontology and Oral Mucosa, The Second Affiliated Hospital of Harbin Medical University, Harbin, China; Heilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address:
Article Synopsis
- Behcet's syndrome causes oral ulcers and involves complex inflammatory processes; this study investigates the relationship between inflammatory cytokines, metabolites, and the disease's development using Mendelian randomization.
- The research analyzed associations between 91 cytokines and 553 metabolites through genetic variants (SNPs) and employed various statistical tests to ensure reliability.
- Five substances, including specific interleukins and a metabolite, were found to be causally related to the syndrome, providing potential markers for diagnosis and treatment, but more research is needed to confirm their efficacy as targets for therapy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!